Literature DB >> 21061757

Lasers for scars: a review and evidence-based appraisal.

Mohamed L Elsaie1, Sonal Choudhary.   

Abstract

Numerous treatment modalities are available for scar management depending upon scar characteristics, age and patient expectations. The focus of this article is to review commonly used nonsurgical methods of scar revision. These include topical applications (e.g., silicone, vitamin E, pressure dressing, herbal extracts), intralesional medication (e.g., steroids, antimitotics), soft-tissue augmentation (e.g., collagen, fat), laser applications (e.g., 585-nm flashlamp-pumped pulsed dye, CO2), cryotherapy and make-up camouflage. Nonsurgical modalities can be used as prophylactic prevention of adverse scar formation, as definitive treatment, as intervening therapy until further surgical repair can be made, or as adjunctive treatment following surgical scar revision. There are several laser systems available that permit successful treatment of various types of scars. The 585-nm PDL remains the gold standard for laser treatment of hypertrophic scars and keloids. Although atrophic scars may best be treated with ablative CO2 and Er:YAG lasers, the intense interest in procedures with reduced morbidity profiles has increased the popularity of nonablative laser procedures. This paper will focus on the use of lasers for scar revision.

Entities:  

Mesh:

Year:  2010        PMID: 21061757

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  3 in total

1.  Surgical scar revision: an overview.

Authors:  Shilpa Garg; Naveen Dahiya; Somesh Gupta
Journal:  J Cutan Aesthet Surg       Date:  2014-01

2.  Early fractional carbon dioxide laser intervention for postsurgical scars in skin of color.

Authors:  Shady M Ibrahim; Wael M Saudi; Mohamed F Abozeid; Mohamed L Elsaie
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-01-04

3.  Pilot Study of the Efficacy of 578 nm Copper Bromide Laser Combined with Intralesional Corticosteroid Injection for Treatment of Keloids and Hypertrophic Scars.

Authors:  In Pyeong Son; Kui Young Park; Beomjoon Kim; Myeung Nam Kim
Journal:  Ann Dermatol       Date:  2014-04-30       Impact factor: 1.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.